Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Treating murine inflammatory diseases with an anti-erythrocyte antibody.

Crow AR, Kapur R, Koernig S, Campbell IK, Jen CC, Mott PJ, Marjoram D, Khan R, Kim M, Brasseit J, Cruz-Leal Y, Amash A, Kahlon S, Yougbare I, Ni H, Zuercher AW, Käsermann F, Semple JW, Lazarus AH.

Sci Transl Med. 2019 Aug 21;11(506). pii: eaau8217. doi: 10.1126/scitranslmed.aau8217.

PMID:
31434758
2.

Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model.

Koernig S, Campbell IK, Mackenzie-Kludas C, Schaub A, Loetscher M, Ching Ng W, Zehnder R, Pelczar P, Sanli I, Alhamdoosh M, Ng M, Brown LE, Käsermann F, Vonarburg C, Zuercher AW.

Mucosal Immunol. 2019 Jul;12(4):1013-1024. doi: 10.1038/s41385-019-0167-z. Epub 2019 May 19.

PMID:
31105268
3.

rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.

Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Käsermann F, Zuercher AW.

J Immunol. 2018 Apr 15;200(8):2542-2553. doi: 10.4049/jimmunol.1701171. Epub 2018 Mar 12.

4.

Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis.

Campbell IK, Leong D, Edwards KM, Rayzman V, Ng M, Goldberg GL, Wilson NJ, Scalzo-Inguanti K, Mackenzie-Kludas C, Lawlor KE, Wicks IP, Brown LE, Baz Morelli A, Panousis C, Wilson MJ, Nash AD, McKenzie BS, Andrews AE.

J Immunol. 2016 Dec 1;197(11):4392-4402. Epub 2016 Nov 2.

5.

G-CSF and Neutrophils Are Nonredundant Mediators of Murine Experimental Autoimmune Uveoretinitis.

Goldberg GL, Cornish AL, Murphy J, Pang ES, Lim LL, Campbell IK, Scalzo-Inguanti K, Chen X, McMenamin PG, Maraskovsky E, McKenzie BS, Wicks IP.

Am J Pathol. 2016 Jan;186(1):172-84. doi: 10.1016/j.ajpath.2015.09.008.

PMID:
26718978
6.

Will sialylation change intravenous immunoglobulin therapy in the future?

Käsermann F, Campbell IK.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:100-2. doi: 10.1111/cei.12528. No abstract available.

7.

Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis.

Liu X, Croker BA, Campbell IK, Gauci SJ, Alexander WS, Tonkin BA, Walsh NC, Linossi EM, Nicholson SE, Lawlor KE, Wicks IP.

Arthritis Rheumatol. 2014 Sep;66(9):2391-402. doi: 10.1002/art.38701.

8.

Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.

Campbell IK, Miescher S, Branch DR, Mott PJ, Lazarus AH, Han D, Maraskovsky E, Zuercher AW, Neschadim A, Leontyev D, McKenzie BS, Käsermann F.

J Immunol. 2014 Jun 1;192(11):5031-8. doi: 10.4049/jimmunol.1301611. Epub 2014 Apr 23.

9.

Bcl-2 overexpression ameliorates immune complex-mediated arthritis by altering FcγRIIb expression and monocyte homeostasis.

Lawlor KE, van Nieuwenhuijze A, Parker KL, Drake SF, Campbell IK, Smith SD, Vince JE, Strasser A, Wicks IP.

J Leukoc Biol. 2013 Apr;93(4):585-97. doi: 10.1189/jlb.0412190. Epub 2013 Jan 22. Erratum in: J Leukoc Biol. 2013 Dec;94(6):1345. J Leukoc Biol. 2013 Dec;94(6):1345.

PMID:
23341540
10.

Differentiation of inflammatory dendritic cells is mediated by NF-κB1-dependent GM-CSF production in CD4 T cells.

Campbell IK, van Nieuwenhuijze A, Segura E, O'Donnell K, Coghill E, Hommel M, Gerondakis S, Villadangos JA, Wicks IP.

J Immunol. 2011 May 1;186(9):5468-77. doi: 10.4049/jimmunol.1002923. Epub 2011 Mar 18.

11.

G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis.

Cornish AL, Campbell IK, McKenzie BS, Chatfield S, Wicks IP.

Nat Rev Rheumatol. 2009 Oct;5(10):554-9. doi: 10.1038/nrrheum.2009.178. Review.

PMID:
19798030
12.

Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.

Campbell IK, Kinkel SA, Drake SF, van Nieuwenhuijze A, Hubert FX, Tarlinton DM, Heath WR, Scott HS, Wicks IP.

Arthritis Rheum. 2009 Jun;60(6):1683-93. doi: 10.1002/art.24501.

13.

Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis.

Egan PJ, van Nieuwenhuijze A, Campbell IK, Wicks IP.

Arthritis Rheum. 2008 Dec;58(12):3720-9. doi: 10.1002/art.24075.

14.

A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis.

Eyles JL, Hickey MJ, Norman MU, Croker BA, Roberts AW, Drake SF, James WG, Metcalf D, Campbell IK, Wicks IP.

Blood. 2008 Dec 15;112(13):5193-201. doi: 10.1182/blood-2008-02-139535. Epub 2008 Sep 29.

PMID:
18824600
15.

The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.

Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Shin Teh J, Lo JC, Rizzitelli A, Wu L, Vremec D, van Dommelen SL, Campbell IK, Maraskovsky E, Braley H, Davey GM, Mottram P, van de Velde N, Jensen K, Lew AM, Wright MD, Heath WR, Shortman K, Lahoud MH.

Blood. 2008 Oct 15;112(8):3264-73. doi: 10.1182/blood-2008-05-155176. Epub 2008 Jul 30.

16.

The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis.

McNeil HP, Shin K, Campbell IK, Wicks IP, Adachi R, Lee DM, Stevens RL.

Arthritis Rheum. 2008 Aug;58(8):2338-46. doi: 10.1002/art.23639.

17.

Otological and vestibular symptoms in patients with low grade (Quebec grades one and two) whiplash injury.

Rowlands RG, Campbell IK, Kenyon GS.

J Laryngol Otol. 2009 Feb;123(2):182-5. doi: 10.1017/S0022215108002569. Epub 2008 May 19.

PMID:
18485253
18.

Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.

Wong PK, Quinn JM, Sims NA, van Nieuwenhuijze A, Campbell IK, Wicks IP.

Arthritis Rheum. 2006 Jan;54(1):158-68.

20.

Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice.

Tan Sardjono C, Mottram PL, van de Velde NC, Powell MS, Power D, Slocombe RF, Wicks IP, Campbell IK, McKenzie SE, Brooks M, Stevenson AW, Hogarth PM.

Arthritis Rheum. 2005 Oct;52(10):3220-9.

21.

ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo.

Little CB, Mittaz L, Belluoccio D, Rogerson FM, Campbell IK, Meeker CT, Bateman JF, Pritchard MA, Fosang AJ.

Arthritis Rheum. 2005 May;52(5):1461-72.

22.

ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.

Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT, Little CB, Last K, Farmer PJ, Campbell IK, Fourie AM, Fosang AJ.

Nature. 2005 Mar 31;434(7033):648-52.

23.
24.

Critical role for granulocyte colony-stimulating factor in inflammatory arthritis.

Lawlor KE, Campbell IK, Metcalf D, O'Donnell K, van Nieuwenhuijze A, Roberts AW, Wicks IP.

Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11398-403. Epub 2004 Jul 22.

25.

Molecular targets in immune-mediated diseases: the case of tumour necrosis factor and rheumatoid arthritis.

Campbell IK, Roberts LJ, Wicks IP.

Immunol Cell Biol. 2003 Oct;81(5):354-66. Review.

PMID:
12969323
26.

The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover.

Wong PK, Campbell IK, Egan PJ, Ernst M, Wicks IP.

Arthritis Rheum. 2003 May;48(5):1177-89. Review. No abstract available.

27.
28.

Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.

Cook AD, Braine EL, Campbell IK, Hamilton JA.

Am J Pathol. 2002 Mar;160(3):917-26.

29.
30.

Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation.

Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, Alexander WS, Wicks IP, Tarlinton DM, Novak U, Heath JK, Dunn AR.

J Exp Med. 2001 Jul 16;194(2):189-203.

31.

Severe inflammatory arthritis and lymphadenopathy in the absence of TNF.

Campbell IK, O'Donnell K, Lawlor KE, Wicks IP.

J Clin Invest. 2001 Jun;107(12):1519-27.

32.

Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis.

Lawlor KE, Campbell IK, O'Donnell K, Wu L, Wicks IP.

Arthritis Rheum. 2001 Feb;44(2):442-50.

33.
34.
35.

Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants.

Fosang AJ, Last K, Stanton H, Weeks DB, Campbell IK, Hardingham TE, Hembry RM.

J Biol Chem. 2000 Oct 20;275(42):33027-37.

36.

Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis.

Campbell IK, Gerondakis S, O'Donnell K, Wicks IP.

J Clin Invest. 2000 Jun;105(12):1799-806.

37.

Targeted insertion of a lacZ reporter gene into the mouse Cer1 locus reveals complex and dynamic expression during embryogenesis.

Stanley EG, Biben C, Allison J, Hartley L, Wicks IP, Campbell IK, McKinley M, Barnett L, Koentgen F, Robb L, Harvey RP.

Genesis. 2000 Apr;26(4):259-64.

PMID:
10748464
39.

Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice.

Campbell IK, Rich MJ, Bischof RJ, Dunn AR, Grail D, Hamilton JA.

J Immunol. 1998 Oct 1;161(7):3639-44.

40.

Audit.

Campbell IK.

Br J Gen Pract. 1997 Oct;47(423):661. No abstract available.

41.

Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice.

Campbell IK, Bendele A, Smith DA, Hamilton JA.

Ann Rheum Dis. 1997 Jun;56(6):364-8.

44.
45.

Plasminogen activators and their inhibitors in arthritic disease.

Hamilton JA, Campbell IK, Wojta J, Cheung D.

Ann N Y Acad Sci. 1992 Dec 4;667:87-100. Review. No abstract available.

PMID:
1309075
46.

Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1.

Campbell IK, Novak U, Cebon J, Layton JE, Hamilton JA.

J Immunol. 1991 Aug 15;147(4):1238-46.

PMID:
1714478
47.

Regulation of plasminogen activator activity in arthritic joints.

Hamilton JA, Hart PH, Leizer T, Vitti GF, Campbell IK.

J Rheumatol Suppl. 1991 Feb;27:106-9.

PMID:
1902874
48.

Recombinant human interleukin-1 inhibits plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes.

Campbell IK, Last K, Novak U, Lund LR, Hamilton JA.

Biochem Biophys Res Commun. 1991 Jan 15;174(1):251-7.

PMID:
1989604
49.
50.

Stimulation of human chondrocyte prostaglandin E2 production by recombinant human interleukin-1 and tumour necrosis factor.

Campbell IK, Piccoli DS, Hamilton JA.

Biochim Biophys Acta. 1990 Mar 9;1051(3):310-8.

PMID:
2310781

Supplemental Content

Loading ...
Support Center